2024. Placebo- Controlled Trial of Pharmaceutical Optimized Lisinopril 10mg (F-5) in Patients with Essential Hypertension for Efficacy & Biochemical Evaluation. Medical Forum Monthly. 25, 12 (Apr. 2024).